ALLMedicine™ Male Breast Cancer Center

Jan 21st, 2023 - Male breast cancer is rare but its incidence and mortality are increasing in the United States, with racial/ethnic disparities in survival reported. There is limited evidence for cardiotoxicity of cancer treatment among men with breast cancer. We ...

Jan 5th, 2023 - Concomitant disease is associated with poor breast cancer survival in women and is more prevalent in racial/ethnic minority groups than individuals who are non-Hispanic White. The purpose of this study was to determine if race/ethnicity is associa...

Dec 31st, 2022 - Breast cancer mortality in women has declined significantly over the past several years. In men, it is unclear whether survival has changed over time. We evaluated changes in breast cancer-specific survival (BCSS) and overall survival (OS) in male...

Dec 24th, 2022 - Research describing male breast cancer with HER2 overexpression is limited. This study evaluated the characteristics, treatment, and outcomes of HER2 positive breast cancer in men. Information for January 2010 through December 2017 was obtained fr...

Dec 19th, 2022 - Up to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population a...

Feb 15th, 2020 - To develop recommendations concerning the management of male breast cancer. ASCO convened an Expert Panel to develop recommendations based on a systematic review and a formal consensus process. Twenty-six descriptive reports or observational studi...

Dec 19th, 2022 - Up to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population a...

Nov 17th, 2022 - Objectives retrospective part (closed to patients registration in September 2013): To perform a large international joint retrospective analysis of clinical and biological data of male breast cancer (BC) patients treated from 1990 to 2010. To crea...

Aug 23rd, 2022 - Background: Advanced breast cancer and endometrial cancer have limited treatment options. Current treatments provide a modest improvement in progression free survival, but no treatments improve survival. ONC201 is the founding member of a novel cl...

Feb 17th, 2022 - The objective of this study is to investigate the potential association between finasteride (MK-0906) exposure and the development of breast cancer in men residing in Denmark, Sweden, Finland, and Norway from data in national registries. The prima...

Sep 19th, 2018 - Breast cancer in men is a rare disease with approximately 0.5- 1% of all breast cancer cases. Each year, about 400 to 450 cases are diagnosed in Germany. Men tend to present with more advanced disease than women, probably due to the lack of awaren...

Oct 29th, 2022 - Erin Roesch, MD The landmark phase 3 CLEOPATRA study demonstrated a 16. 3-month improvement in overall survival (OS) at 8 years of follow-up with docetaxel/trastuzumab/pertuzumab (THP) vs docetaxel/trastuzumab in human epidermal growth factor recep.

Oct 24th, 2022 - Key clinical point: Male patients who survived breast cancer (BC) were more likely to develop second primary cancers (SPC), such as colorectal, pancreatic, and thyroid cancers. Major finding: Standardized incidence ratio (SIR) of any SPC was estim.

Aug 26th, 2022 - The use of metformin and testosterone replacement therapy, either individually or in combination, is associated with significant reductions in the incidence of prostate and colorectal cancer in men across race and ethnic backgrounds, with the redu...

May 24th, 2022 - Male breast cancer is linked to infertility, according to a new case-control study from the Institute of Cancer Research in London. The report follows other studies that generally failed to identify a statistically significant association, but the.

May 20th, 2022 - Medicaid expansion under the Affordable Care Act was associated with significantly improved cancer survival, particularly among non-Hispanic Blacks and people living in rural areas. (American Cancer Society, Journal of the National Cancer Institut...